Skip to main content

Fiera Capital Corp

Position in NBIX — Neurocrine Biosciences Inc

CIK 1505817 MONTREAL, A8

Position in NBIX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$85,796,333
-$4,607,243 QoQ
Shares Held
651,255
+2.2% QoQ
Ownership
0.648%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority Sole 36.17477025128406.ToString("F0")% Shared 2.3396365478959855.ToString("F0")% None 61.485593200819956.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Fiera Capital Corp holds $101,934,361 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (84.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
651,255 $85,796,333

All Filings in NBIX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $85,796,333 651,255
2025-12-31 $90,403,576 637,408
2025-09-30 $67,336,916 479,676
2025-06-30 $61,662,759 490,594
2025-03-31 $54,688,934 494,475
2024-12-31 $68,128,378 499,109
2024-09-30 $59,545,810 516,801
2024-06-30 $72,676,267 527,902
2024-03-31 $70,551,872 511,542
2023-12-31 $68,102,131 516,865
2023-09-30 $57,528,900 511,368
2023-06-30 $33,757,042 357,975
2023-03-31 $37,387,327 369,367
2022-12-31 $44,493,668 372,519
2022-09-30 $39,837,989 375,087
2022-06-30 $36,926,008 378,806
2022-03-31 $35,970,562 383,686
2021-12-31 $30,990,977 363,872
2021-09-30 $38,601,089 402,472
2021-03-31 $40,670,922 418,210
2020-12-31 $39,516,653 412,276
2020-09-30 $27,465,699 285,625